First Pacific Financial »

Vertex Pharmaceuticals Incorporated shares owned by First Pacific Financial

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by First Pacific Financial from 13F filings

Historical chart of First Pacific Financial investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by First Pacific Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by First Pacific Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $455k 978 465.08
2024-06-30 $433k 924 468.72
2024-03-31 $375k 898 418.01
2023-12-31 $340k 836 406.89
2023-09-30 $272k 783 347.74
2023-06-30 $219k 621 351.91

More positions owned by First Pacific Financial

Vanguard Index Fds Growth Etf (VUG)
Ishares Tr S&p 100 Etf (OEF)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
Matthews Intl Fds Pacific Tiger Ac (ASIA)
Dimensional Etf Trust World Equity Etf (DFAW)
Schwab Strategic Tr Fundamental Us S (FNDA)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Nushares Etf Tr Nuveen Esg Us (NUBD)
Manager Directed Portfolios Vert Glb Sust Re (VGSR)
Matthews Intl Fds Emerging Markets (EMSF)
Morgan Stanley Etf Trust Calvert Us Mdcp (CVMC)
Nushares Etf Tr Nuveen Esg Smlcp (NUSC)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Tcw Unconstrai (UCON)

View all positions for First Pacific Financial

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
BlackRock
State Street Corporation
Capital Research Global Investors
Alliancebernstein
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates
Amundi
Morgan Stanley
Massachusetts Financial Services
Bank of America Corporation
Henderson Group

View all funds holding Vertex Pharmaceuticals Incorporated